Analysts impressed as J&J acquires $1 billion stake in Elan
03/07/2009
In a deal warmly welcomed by analysts, Ireland’s Elan Corp has a sold a major stake in the firm and the rights to its portfolio of Alzheimer’s disease investigational drugs to Johnson & Johnson in return for $1 billion
Eisai to file new Aricept formulation, wants out of Pfizer pact
02/07/2009
Eisai is looking to file a new formulation of Aricept this summer and is confident about terminating its collaboration with Pfizer, the Japanese drugmaker’s marketing partner for the Alzheimer's disease blockbuster
Roche/Genentech to seek a new approval for Lucentis
03/07/2009
Roche’s Genentech unit has presented promising data which it hopes will result in an approval for a second indication of the sight drug Lucentis
FDA concerned about King/Acura's painkiller Acurox
03/07/2009
King Pharmaceuticals and Acura are facing a deal in getting their painkiller Acurox onto the market after regulators in the USA issued a letter expressing concerns about the drug's abuse-deterrent properties
